with RFK potentially being head of HHS, is it really doom for Big Pharma like Lily, Novo, Abbive, Astrazeneca, Merck, etc etc

I really dont want to leave biotech, but if RFK is really that horrible to the sector, do i need to go back to HiTech? i know only time will tell, but anyone who comb thru RFK records, what does the future hold for biotech?